Skip to main content
FDA Shortage Check

Is Bicillin L-A (Penicillin G Benzathine Injection) in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Bicillin L-A: in shortage (FDA, Oct 24)

Injections (vials)
A generic injection, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
  • Reason: “Other”. FDA shortage reason (FDASIA), reported by the manufacturer
  • Estimate: “Estimated Recovery: September 2027”. Manufacturer’s estimate, Pfizer Inc., Oct 21, 2026
  • Estimate: “Estimated Recovery: December 2027”. Manufacturer’s estimate, Pfizer Inc., Oct 21, 2026
DRUG
Bicillin L-A
FDA LISTING
FORM
injection
STATUS
Currently in Shortage
FIRST POSTED
Apr 26, 2023
LAST FDA UPDATE
Oct 21, 2026
AS OF
Oct 24, 2026
SOURCE

FDA lists 4 presentations: 1 unavailable · 2 limited · 1 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Penicillin G Benzathine Injection. 4 presentations from 2 makers.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Pfizer Inc.3 presentations · 1 unavailable · 2 limited

Contact (FDA's listing): 800-533-4535

  • 600000 [iU]/1 mL

    Bicillin L-A, Injection, 600000 [iU]/1 mL (NDC 60793-700-10)

    Next Delivery: October 2027; Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay

    NDC 60793-700-10Revised

    Unavailable

  • 1200000 [iU]/2 mL

    Bicillin L-A, Injection, 1200000 [iU]/2 mL (NDC 60793-701-10)

    Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay

    NDC 60793-701-10Revised

    Limited Availability

  • 2400000 [iU]/4 mL

    Bicillin L-A, Injection, 2400000 [iU]/4 mL (NDC 60793-702-10)

    Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay

    NDC 60793-702-10Revised

    Limited Availability

Laboratorios Atral1 presentation · 1 available or not stated

Contact (FDA's listing): Mark Cuban Cost Plus Drug Company: 682-428-8081

  • 1200000 U/4 mL

    Lentocilin, Injection, 1200000 U/4 mL (NDC 84383-110-01)

    NDC 84383-110-01Reverified

    Available

What the manufacturers told FDA

  • Pfizer Inc. · ‘Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay’ · updated Oct 2026
  • Pfizer Inc. · ‘Next Delivery: October 2027; Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay’ · updated Oct 2026

More on FDA ↗ (opens in a new tab)

Reason for the shortage (FDASIA)

  • Other

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Bicillin L-A in shortage?
Yes. As of Oct 24, 2026, FDA lists Penicillin G Benzathine Injection as currently in shortage: 4 presentations, 1 unavailable and 2 limited.
When will the Bicillin L-A shortage end?
FDA gives no end date. 3 presentations carry a manufacturer’s own estimate, quoted on this page with its date.
Does FDA list alternatives to Bicillin L-A?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.